References
- Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows
AT, et al. Chronic health conditions in adult survivors of childhood
cancer. N Engl J Med 2006;355(15):1572‐1582.
- Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson
MM, et al. Aging and risk of severe, disabling, life-threatening, and
fatal events in the childhood cancer survivor study. J Clin Oncol
2014;32(12):1218–27.
- Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima
TI, et al. Chronic disease in the childhood cancer survivor study
cohort: a review of published findings. J Clin Oncol
2009;27(14):2339–55.
- Meshref M, ElShazly N, Nasr M and AbdElhai R. Effect of different
doses of prophylactic cranial irradiation in childhood lymphoblastic
leukemia on CNS relapse, late cognitive decline and learning
disabilities. journal of Cancer Therapeutics and Research 2013, 2:10.
- Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, et
al. Treatment of children with medulloblastomas with reduced-dose
craniospinal radiation therapy and adjuvant chemotherapy: A Children’s
Cancer Group Study. J Clin Oncol. 1999;17(7):2127‐2136.
- Casey DL, Kushner BH, Cheung N KV, Roberts SS, LaQuaglia MP, Wolden
SL, et al. Reduced-dose radiation therapy to the primary site is
effective for high-risk neuroblastoma: results from a prospective
trial. Int
J Radiat Oncol Biol Phys. 2019;104(2):409-414.
- Kahalley LS, Peterson R, Ris MD, Janzen L, Okcu MF, Grosshans DR,
Ramaswamy V, et al. Superior Intellectual Outcomes After Proton
Radiotherapy Compared with Photon Radiotherapy for Pediatric
Medulloblastoma. J Clin Oncol. 2020;38:454-61.
- Eaton BR, Esiashvili N, Kim S, et al. Endocrine outcomes with proton
and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol
2016;18:88;1–7.
- Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ. Incidence
of second malignancies among patients treated with proton versus
photon radiation. Int J Radiat Oncol Biol Phys 2013;87:46–52.
- Sardaro A, Carbonara R, Petruzzelli MF, Turi B, Moschetta M,
Scardapane A, et al. Proton therapy in the most common pediatric
non-central nervous system malignancies: an overview of clinical and
dosimetric outcomes. Ital J Pediatr 2019;45(1):170.
- Yock TI, Bhat S, Szymonifka J, et al. Quality of life outcomes in
proton and photon treated pediatric brain tumor survivors. Radiother
Oncol 2014;113:89–94.
- Breneman JC, Donaldson SS, Constine L, Merchant T, Marcus K, Paulino
A, et al. The Children’s Oncology Group Radiation Oncology Discipline:
15 Years of Contribution to the Treatment of Childhood Cancer. Int J
Radiat Oncol Biol Phys 2018;101(4):860-874.
- Weber DC, Habrand JL, Hoppe BS, Kayser CH, Laack NN, Langendijk JA, et
al. Proton therapy for pediatric malignancies: Fact, figures and
costs. A joint consensus statement from the pediatric subcommittee of
PTCOG, PROS and EPTN. Radiother Oncol . 2018;128(1):44‐55.
- Indelicato D, Merchant T, Leperriere N, Lassen Y, Vennarini S, Wolden
S, et al. Consensus report from the Stockholm pediatric proton therapy
conference. Int J Radiat Oncol Biol Phys 2016;96(2):387-392.
- Tonse R, Noufal MP, Deopujari CE, Jalali R. India’s first proton beam
therapy pediatric patient. Neurol India 2020;68(1):189-191.
- Tonse R, Chilukuri S, Shamurailatpam D, Jalali R. Introduction of
image guided pencil beam scanning proton therapy for skull base tumors
in India: A report of two cases and a brief review of literature.
Neurol India 2020;68(1):42-44.
- Chilukuri S, Jalali R, Panda PK. Survey on variations of knowledge and
perception amongst radiation oncologists across India regarding proton
beam therapy. Int J Particle Therapy 2020;6(4):PTC58-0527.
- Odei B, Frandsen JE, Boothe D, Ermoian RP, Poppe MM. Patterns of Care
in Proton radiation therapy for pediatric central nervous system
malignancies. Int J Radiat Oncol Biol Phys 2017;97(1):60–3.
- Hess CB, Indelicato DJ, Paulino AC, Hartsell WF, Hill-Kayser CE,
Perkins SM, et al. An update from the Pediatric Proton Consortium
Registry. Front Oncol 2018;8:165.
- Carbonara R, Di Rito A, Monti A, Rubini G, Sardaro A. Proton versus
photon radiotherapy for pediatric central nervous system malignancies:
A systematic review and meta-Analysis of dosimetric comparison
studies. J Oncol 2019:5879723.
- Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, et
al. Long‐term toxic effects of proton radiotherapy for paediatric
medulloblastoma: a phase 2 single‐arm study. Lancet
Oncol. 2016;17:287‐ 298.
- Cotter SE, Herrup DA, Friedmann A, et al. Proton radiotherapy for
pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and
dosimetry compared to intensity-modulated radiation therapy. Int J
Radiat Oncol Biol Phys 2011;81:1367–73.
- Jalali R, Gupta T, Goda JS, Goswami S, Shah N, Dutta D, et al.
Efficacy of stereotactic conformal radiotherapy vs conventional
radiotherapy on benign and low-grade brain tumors: a Randomized
clinical trial. JAMA Oncol 2017;3(10)1368-1376.
- Paganetti H. Relative biological effectiveness (RBE) values for proton
beam therapy. Variations as function of biological endpoint, dose,
and linear energy transfer. Phys Med Biol 2014;59(22):R419-72.
- Ladra MM, Szymonifka JD, Mahajan A, Friedmann AM, Yeap BY, Goebel CP,
et al. Preliminary results of a phase II trial of proton radiotherapy
for pediatric rhabdomyosarcoma.J Clin Oncol 2014;32(33):3762‐3770.
- Suneja G, Poorvu PD, Hill-Kayser C, Lustig RA. Acute toxicity of
proton beam radiation for pediatric central nervous system
malignancies. Pediatr Blood Cancer 2013;60(9):1431–6.
- Selo N, Bölling T, Ernst I, Pape H, Martini C, Rübe C, et al. Acute
toxicity profile of radiotherapy in 690 children and adolescents: RiSK
data. Radiother Oncol 2010;97(1):119–26.
- Song S, Park HJ, Yoon JH, et al. Proton beam therapy reduces the
incidence of acute haematological and gastrointestinal toxicities
associated with craniospinal irradiation in pediatric brain tumors.
Acta Oncol 2014;53:1158–64.
- Bujold A, Craig T, Jaffray D, Dawson LA. Image-guided radiotherapy:
Has it influenced patient outcomes? Semin Radiat Oncol 2012;22:50-61.
- Alcorn SR, Chen MJ, Claude L,Dieckmann K, Ermoian RP,Ford EC, et al.
Practice patterns of photon and proton pediatric image guided
radiation treatment: results from an International Pediatric Research
consortium. Pract Radiat Oncol . 2014;4(5):336‐341.
- Three Year Report of the Population Based Cancer Registries 2012-2014:
Report of 27 PBCRs; National Cancer Registry Programme, Indian Council
Medical Research, Bangalore. 2016.
- Lundkvist J, Ekman M, Ericsson SR, Jönsson B, Glimelius B. Proton
therapy of cancer: potential clinical advantages and
cost-effectiveness. Acta Oncol 2005;44(8):850‐861.
- Lundkvist J, Ekman M, Ericsson SR, Jönsson B, Glimelius B.
Cost-effectiveness of proton radiation in the treatment of childhood
medulloblastoma. Cancer 2005;103(4):793–801.
- Mailhot Vega R, Kim J, Hollander A, et al. Cost effectiveness of
proton versus photon radiation therapy with respect to the risk of
growth hormone deficiency in children. Cancer 2015;121:1694–702.
- Verma V, Mishra MV, Mehta MP. A systematic review of the cost and
cost-effectiveness studies of proton radiotherapy. Cancer
2016;122(10):1483–501.
- Noticewala SS, Williamson CW, Murphy JD. Cost-effectiveness of proton
therapy for parameningeal rhabdomyosarcoma. Int J Radiat Oncol Biol
Phys 2016;96(2)supplement:e398.
- Chilukuri S, Panda PK, Jalali R. PITChing(professional organizations,
innovative clinical trial design and collaborative approach) for
evidence generation for proton therapy. RadiatOncol2020;15:138
https://doi.org/10.1186/s13014-020-01538-y
KEY WORDS: proton beam therapy, demography, acute toxicities,
children, adolescent